APA (7th ed.) Citation

Sharif, H., Arsalan, S., Rehman, N., Muzammil, A., Hatif, F., Wasti, F., . . . Omair, W. (2025). Comparative effects of empagliflozin and metformin on metabolic dysfunction in polycystic ovary syndrome, a double blinded randomized control feasibility trial. BMC Women's Health, 25(1), 1. https://doi.org/10.1186/s12905-025-04091-6

Chicago Style (17th ed.) Citation

Sharif, Hina, et al. "Comparative Effects of Empagliflozin and Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome, a Double Blinded Randomized Control Feasibility Trial." BMC Women's Health 25, no. 1 (2025): 1. https://doi.org/10.1186/s12905-025-04091-6.

MLA (9th ed.) Citation

Sharif, Hina, et al. "Comparative Effects of Empagliflozin and Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome, a Double Blinded Randomized Control Feasibility Trial." BMC Women's Health, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12905-025-04091-6.